ArticleAnalytical chemistry2026
Untargeted Multiple Reaction Monitoring.
Article in Analytical chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
18 authors.
Funding
Abstract
Multiple reaction monitoring (MRM) enables robust and sensitive quantification but traditionally requires predefined precursor-fragment transitions, limiting its use in discovery-driven studies. Here, we describe untargeted/micro/universal multiple reaction monitoring (uMRM), a workflow that converts high-resolution untargeted liquid chromatography-mass spectrometry/MS (LC-MS/MS) data into scheduled triple-quadrupole MRM transitions. Pooled-sample LC-MS and stepped-energy DDA MS/MS acquisitions (0, 10, 20, and 40 eV) are used to capture precursor and fragment information representative of each experimental set. Detected features undergo automated deisotoping and empirically validated in-source fragment filtering, followed by spline-based modeling of collision-energy-dependent fragmentation to define optimized precursor-fragment transitions. Transitions are scheduled using retention times observed in pooled samples and deployed on triple-quadrupole instruments without requiring nonlinear retention-time alignment or authentic standards. Across representative biological matrices, including urine, brain tissue, and cultured cells, uMRM enabled automated generation of quantitative MRM methods from untargeted discovery data. Benchmarking across seven triple-quadrupole platforms demonstrated strong agreement between uMRM-derived and experimentally optimized collision energies. By converting discovery-scale data sets into compact transition tables suitable for quantitative deployment, uMRM provides a reproducible approach for linking untargeted LC-MS/MS acquisition with targeted quantitation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.